www.dynavax.com Open in urlscan Pro
69.63.141.106  Public Scan

Submitted URL: http://dynavax.com/
Effective URL: https://www.dynavax.com/
Submission: On January 30 via manual from US — Scanned from DE

Form analysis 0 forms found in the DOM

Text Content

Skip to main content

 * About
    * Overview
    * Management
    * Board of Directors
    * Scientific Advisory Board
    * Dynavax Europe

 * Product
    * HEPLISAV-B®

 * Science
    * Overview
    * Publications & Presentations
    * CpG 1018®

 * Pipeline
    * Clinical Trials

 * Investors
    * Overview
    * Press Releases
    * Events & Presentations
    * Stock Information
    * Analyst Coverage
    * Financials
    * SEC Filings
    * Annuals and Proxies
    * Corporate Governance and Compliance
       * Board of Directors
       * Committee Composition
       * Contact the Board
   
    * Contact Us

 * Careers
    * Join Our Team
    * Values
    * Job Opportunities
    * Benefits

 * Contact




PREVENTING INFECTIOUS DISEASES WITH PROVEN ADJUVANT TECHNOLOGY


COMMITTED TO DEVELOPING
NOVEL VACCINES

We are a commercial-stage biopharmaceutical company committed to developing and
commercializing novel vaccines to help protect the world against infectious
diseases, by utilizing proven, innovative adjuvant technology.

who we are


MAKE A DIFFERENCE


JOIN A DYNAMIC TEAM DEDICATED TO MAKING A DIFFERENCE

Our mission and passion for what we do are guided by the collective ideals
underpinning Our Values, and these form the basis of our company culture.

Join Us


EMPOWER


RECENT NEWS

Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2023
Financial Highlights

Jan 08, 2024

Dynavax to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Jan 03, 2024

Dynavax to Present at the 6th Annual Evercore ISI HealthCONx Conference

Nov 20, 2023

View More News

DYNAVAX®, HEPLISAV-B®, and CpG 1018® are registered trademarks of Dynavax
Technologies Corporation.

 * Home
 * About
    * Overview
    * Management
    * Board of Directors
    * Scientific Advisory Board
    * Dynavax Europe

 * Product
    * HEPLISAV-B®

 * Science
    * Overview
    * Publications & Presentations
    * CpG 1018®

 * Pipeline
    * Clinical Trials

 * Investors
    * Overview
    * Press Releases
    * Events & Presentations
    * Stock Information
    * Analyst Coverage
    * Financials
    * SEC Filings
    * Annuals and Proxies
    * Corporate Governance and Compliance
       * Board of Directors
       * Committee Composition
       * Contact the Board
   
    * Contact Us

 * Careers
    * Join Our Team
    * Values
    * Job Opportunities
    * Benefits

 * Contact
 * Twitter LinkedIn
 * Terms of Use
 * Privacy Notice

© 2024 Dynavax Technologies. All rights reserved.
 * Terms of Use
 * Privacy Notice

Website Design: Hane Chow, Inc.

US-20-00-00098

Move to next frame
Move to previous frame
Close modal